S100A6 binds to annexin 2 in pancreatic cancer cells and promotes pancreatic cancer cell motility View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2009-09-01

AUTHORS

T Nedjadi, N Kitteringham, F Campbell, R E Jenkins, B K Park, P Navarro, F Ashcroft, A Tepikin, J P Neoptolemos, E Costello

ABSTRACT

Background:High levels of S100A6 have been associated with poor outcome in pancreatic cancer patients. The functional role of S100A6 is, however, poorly understood.Methods:Immunoprecipitation followed by two-dimensional gel electrophoresis and mass spectrometry were undertaken to identify S100A6 interacting proteins in pancreatic cancer cells. Immunohistochemistry and coimmunofluorescence were performed to examine expression or colocalisation of proteins. siRNA was used to deplete specific proteins and effects on motility were measured using Boyden Chamber and wound healing assays.Results:Our proteomic screen to identify S100A6 interacting proteins revealed annexin 11, annexin 2, tropomyosin β and a candidate novel interactor lamin B1. Of these, annexin 2 was considered particularly interesting, as, like S100A6, it is expressed early in the development of pancreatic cancer and overexpression occurs with high frequency in invasive cancer. Reciprocal immunoprecipitation confirmed the interaction between annexin 2 and S100A6 and the proteins colocalised, particularly in the plasma membrane of cultured pancreatic cancer cells and primary pancreatic tumour tissue. Analysis of primary pancreatic cancer specimens (n=55) revealed a strong association between high levels of cytoplasmic S100A6 and the presence of annexin 2 in the plasma membrane of cancer cells (P=0.009). Depletion of S100A6 was accompanied by diminished levels of membrane annexin 2 and caused a pronounced reduction in the motility of pancreatic cancer cells.Conclusion:These findings point towards a functional role for S100A6 that may help explain the link between S100A6 expression in pancreatic cancer and aggressive disease. More... »

PAGES

1145-1154

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.bjc.6605289

DOI

http://dx.doi.org/10.1038/sj.bjc.6605289

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1030007607

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/19724273


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Annexin A2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Cycle Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Line, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Movement", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Proliferation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cytoplasm", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunoprecipitation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pancreatic Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "RNA Interference", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "S100 Calcium Binding Protein A6", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "S100 Proteins", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Division of Surgery and Oncology, University of Liverpool, Liverpool, UK", 
          "id": "http://www.grid.ac/institutes/grid.10025.36", 
          "name": [
            "Division of Surgery and Oncology, University of Liverpool, Liverpool, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nedjadi", 
        "givenName": "T", 
        "id": "sg:person.01033302001.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01033302001.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK", 
          "id": "http://www.grid.ac/institutes/grid.10025.36", 
          "name": [
            "Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kitteringham", 
        "givenName": "N", 
        "id": "sg:person.01264420373.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01264420373.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, University of Liverpool, Liverpool, UK", 
          "id": "http://www.grid.ac/institutes/grid.10025.36", 
          "name": [
            "Department of Pathology, University of Liverpool, Liverpool, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Campbell", 
        "givenName": "F", 
        "id": "sg:person.0646035141.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0646035141.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK", 
          "id": "http://www.grid.ac/institutes/grid.10025.36", 
          "name": [
            "Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jenkins", 
        "givenName": "R E", 
        "id": "sg:person.0756336504.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0756336504.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK", 
          "id": "http://www.grid.ac/institutes/grid.10025.36", 
          "name": [
            "Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Park", 
        "givenName": "B K", 
        "id": "sg:person.010730736267.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010730736267.50"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Research Programme, Municipal Institute of Medical Research, Barcelona, Spain", 
          "id": "http://www.grid.ac/institutes/grid.416319.8", 
          "name": [
            "Cancer Research Programme, Municipal Institute of Medical Research, Barcelona, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Navarro", 
        "givenName": "P", 
        "id": "sg:person.0632005147.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632005147.63"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Baylor College of Medicine, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.39382.33", 
          "name": [
            "Baylor College of Medicine, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ashcroft", 
        "givenName": "F", 
        "id": "sg:person.01234751707.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01234751707.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Physiology, University of Liverpool, Liverpool, UK", 
          "id": "http://www.grid.ac/institutes/grid.10025.36", 
          "name": [
            "Department of Physiology, University of Liverpool, Liverpool, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tepikin", 
        "givenName": "A", 
        "id": "sg:person.0741057222.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0741057222.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Surgery and Oncology, University of Liverpool, Liverpool, UK", 
          "id": "http://www.grid.ac/institutes/grid.10025.36", 
          "name": [
            "Division of Surgery and Oncology, University of Liverpool, Liverpool, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Neoptolemos", 
        "givenName": "J P", 
        "id": "sg:person.012537142122.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012537142122.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Surgery and Oncology, University of Liverpool, Liverpool, UK", 
          "id": "http://www.grid.ac/institutes/grid.10025.36", 
          "name": [
            "Division of Surgery and Oncology, University of Liverpool, Liverpool, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Costello", 
        "givenName": "E", 
        "id": "sg:person.0667260706.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0667260706.15"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/978-1-4020-6191-2_5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052814055", 
          "https://doi.org/10.1007/978-1-4020-6191-2_5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1201564", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024213798", 
          "https://doi.org/10.1038/sj.onc.1201564"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1054/bjoc.2000.1356", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050416973", 
          "https://doi.org/10.1054/bjoc.2000.1356"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrm1661", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033554200", 
          "https://doi.org/10.1038/nrm1661"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2009-09-01", 
    "datePublishedReg": "2009-09-01", 
    "description": "Background:High levels of S100A6 have been associated with poor outcome in pancreatic cancer patients. The functional role of S100A6 is, however, poorly understood.Methods:Immunoprecipitation followed by two-dimensional gel electrophoresis and mass spectrometry were undertaken to identify S100A6 interacting proteins in pancreatic cancer cells. Immunohistochemistry and coimmunofluorescence were performed to examine expression or colocalisation of proteins. siRNA was used to deplete specific proteins and effects on motility were measured using Boyden Chamber and wound healing assays.Results:Our proteomic screen to identify S100A6 interacting proteins revealed annexin 11, annexin 2, tropomyosin \u03b2 and a candidate novel interactor lamin B1. Of these, annexin 2 was considered particularly interesting, as, like S100A6, it is expressed early in the development of pancreatic cancer and overexpression occurs with high frequency in invasive cancer. Reciprocal immunoprecipitation confirmed the interaction between annexin 2 and S100A6 and the proteins colocalised, particularly in the plasma membrane of cultured pancreatic cancer cells and primary pancreatic tumour tissue. Analysis of primary pancreatic cancer specimens (n=55) revealed a strong association between high levels of cytoplasmic S100A6 and the presence of annexin 2 in the plasma membrane of cancer cells (P=0.009). Depletion of S100A6 was accompanied by diminished levels of membrane annexin 2 and caused a pronounced reduction in the motility of pancreatic cancer cells.Conclusion:These findings point towards a functional role for S100A6 that may help explain the link between S100A6 expression in pancreatic cancer and aggressive disease.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/sj.bjc.6605289", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2780638", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "101"
      }
    ], 
    "keywords": [
      "pancreatic cancer cells", 
      "cancer cells", 
      "pancreatic cancer", 
      "primary pancreatic cancer specimens", 
      "pancreatic cancer cell motility", 
      "pancreatic cancer patients", 
      "cultured pancreatic cancer cells", 
      "pancreatic cancer specimens", 
      "pancreatic tumor tissues", 
      "poor outcome", 
      "aggressive disease", 
      "invasive cancer", 
      "cancer patients", 
      "cancer cell motility", 
      "functional role", 
      "cancer specimens", 
      "S100A6 expression", 
      "tumor tissue", 
      "Boyden chamber", 
      "healing assays", 
      "cancer", 
      "strong association", 
      "diminished levels", 
      "high levels", 
      "S100A6", 
      "pronounced reduction", 
      "plasma membrane", 
      "cells", 
      "motility", 
      "two-dimensional gel electrophoresis", 
      "proteomic screen", 
      "patients", 
      "cell motility", 
      "high frequency", 
      "immunohistochemistry", 
      "expression", 
      "protein", 
      "immunoprecipitation", 
      "levels", 
      "disease", 
      "reciprocal immunoprecipitation", 
      "lamin B1", 
      "outcomes", 
      "specific proteins", 
      "siRNA", 
      "gel electrophoresis", 
      "tissue", 
      "association", 
      "role", 
      "overexpression", 
      "colocalisation", 
      "assays", 
      "membrane", 
      "findings", 
      "B1", 
      "depletion", 
      "mass spectrometry", 
      "specimens", 
      "coimmunofluorescence", 
      "reduction", 
      "effect", 
      "presence", 
      "screen", 
      "frequency", 
      "electrophoresis", 
      "development", 
      "analysis", 
      "chamber", 
      "link", 
      "spectrometry", 
      "interaction"
    ], 
    "name": "S100A6 binds to annexin 2 in pancreatic cancer cells and promotes pancreatic cancer cell motility", 
    "pagination": "1145-1154", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1030007607"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.bjc.6605289"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "19724273"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.bjc.6605289", 
      "https://app.dimensions.ai/details/publication/pub.1030007607"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:27", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_478.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/sj.bjc.6605289"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6605289'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6605289'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6605289'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6605289'


 

This table displays all metadata directly associated to this object as RDF triples.

273 TRIPLES      21 PREDICATES      112 URIs      100 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.bjc.6605289 schema:about N0556efa3fb604abaa407cfa4c6bc7d90
2 N3c9dd842f0f74ee2983a6af4bc04bf6e
3 N4801e2f224ab4a26a468af885e5aca87
4 N56685bb6f9ef4482b34995b196ca86c2
5 N5bc6c15b235f4a5694c9bace227213eb
6 N7a04069b61e94e3e98cd328a6ced8e38
7 N7acf0e312252418c82a6ca11366b99fe
8 N8043ba9bb15048a785d116222b733097
9 N8d20b305cc9e42bcabc9b0c206dfdc4e
10 N8d8cb612c37d40669418a67bd45cb7e2
11 Na88c7505fa9f46e0adf54efe71eb3e76
12 Nebd2ba7c404046e5a8ccdfba19c7100c
13 anzsrc-for:11
14 anzsrc-for:1112
15 schema:author Nc0af53352ad04b13a968ad3e56baa4e8
16 schema:citation sg:pub.10.1007/978-1-4020-6191-2_5
17 sg:pub.10.1038/nrm1661
18 sg:pub.10.1038/sj.onc.1201564
19 sg:pub.10.1054/bjoc.2000.1356
20 schema:datePublished 2009-09-01
21 schema:datePublishedReg 2009-09-01
22 schema:description Background:High levels of S100A6 have been associated with poor outcome in pancreatic cancer patients. The functional role of S100A6 is, however, poorly understood.Methods:Immunoprecipitation followed by two-dimensional gel electrophoresis and mass spectrometry were undertaken to identify S100A6 interacting proteins in pancreatic cancer cells. Immunohistochemistry and coimmunofluorescence were performed to examine expression or colocalisation of proteins. siRNA was used to deplete specific proteins and effects on motility were measured using Boyden Chamber and wound healing assays.Results:Our proteomic screen to identify S100A6 interacting proteins revealed annexin 11, annexin 2, tropomyosin β and a candidate novel interactor lamin B1. Of these, annexin 2 was considered particularly interesting, as, like S100A6, it is expressed early in the development of pancreatic cancer and overexpression occurs with high frequency in invasive cancer. Reciprocal immunoprecipitation confirmed the interaction between annexin 2 and S100A6 and the proteins colocalised, particularly in the plasma membrane of cultured pancreatic cancer cells and primary pancreatic tumour tissue. Analysis of primary pancreatic cancer specimens (n=55) revealed a strong association between high levels of cytoplasmic S100A6 and the presence of annexin 2 in the plasma membrane of cancer cells (P=0.009). Depletion of S100A6 was accompanied by diminished levels of membrane annexin 2 and caused a pronounced reduction in the motility of pancreatic cancer cells.Conclusion:These findings point towards a functional role for S100A6 that may help explain the link between S100A6 expression in pancreatic cancer and aggressive disease.
23 schema:genre article
24 schema:isAccessibleForFree true
25 schema:isPartOf N2187a7cb191b4a49988ea87c5c8770de
26 Naef1a03d7dbe4094a8668190f0167f2d
27 sg:journal.1017082
28 schema:keywords B1
29 Boyden chamber
30 S100A6
31 S100A6 expression
32 aggressive disease
33 analysis
34 assays
35 association
36 cancer
37 cancer cell motility
38 cancer cells
39 cancer patients
40 cancer specimens
41 cell motility
42 cells
43 chamber
44 coimmunofluorescence
45 colocalisation
46 cultured pancreatic cancer cells
47 depletion
48 development
49 diminished levels
50 disease
51 effect
52 electrophoresis
53 expression
54 findings
55 frequency
56 functional role
57 gel electrophoresis
58 healing assays
59 high frequency
60 high levels
61 immunohistochemistry
62 immunoprecipitation
63 interaction
64 invasive cancer
65 lamin B1
66 levels
67 link
68 mass spectrometry
69 membrane
70 motility
71 outcomes
72 overexpression
73 pancreatic cancer
74 pancreatic cancer cell motility
75 pancreatic cancer cells
76 pancreatic cancer patients
77 pancreatic cancer specimens
78 pancreatic tumor tissues
79 patients
80 plasma membrane
81 poor outcome
82 presence
83 primary pancreatic cancer specimens
84 pronounced reduction
85 protein
86 proteomic screen
87 reciprocal immunoprecipitation
88 reduction
89 role
90 screen
91 siRNA
92 specific proteins
93 specimens
94 spectrometry
95 strong association
96 tissue
97 tumor tissue
98 two-dimensional gel electrophoresis
99 schema:name S100A6 binds to annexin 2 in pancreatic cancer cells and promotes pancreatic cancer cell motility
100 schema:pagination 1145-1154
101 schema:productId N35df1937e9534601ad3908b56c096d87
102 Na2ae18d3903e48c5a39d2369cc33340c
103 Nf9c739be3abc4786aa2b1f994f87048b
104 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030007607
105 https://doi.org/10.1038/sj.bjc.6605289
106 schema:sdDatePublished 2022-12-01T06:27
107 schema:sdLicense https://scigraph.springernature.com/explorer/license/
108 schema:sdPublisher N799de97dc9b847608360f85cc747675d
109 schema:url https://doi.org/10.1038/sj.bjc.6605289
110 sgo:license sg:explorer/license/
111 sgo:sdDataset articles
112 rdf:type schema:ScholarlyArticle
113 N04bc6049d0404909a8628ca2db6b29ec rdf:first sg:person.0646035141.16
114 rdf:rest Na760a7ff9b3a4162b7047ce9a4076cef
115 N0556efa3fb604abaa407cfa4c6bc7d90 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name RNA Interference
117 rdf:type schema:DefinedTerm
118 N1badff11677b476eb116b4e4f827764b rdf:first sg:person.012537142122.12
119 rdf:rest N3bfd0833c71c428b835169c18e4af77d
120 N2187a7cb191b4a49988ea87c5c8770de schema:volumeNumber 101
121 rdf:type schema:PublicationVolume
122 N35df1937e9534601ad3908b56c096d87 schema:name doi
123 schema:value 10.1038/sj.bjc.6605289
124 rdf:type schema:PropertyValue
125 N3bfd0833c71c428b835169c18e4af77d rdf:first sg:person.0667260706.15
126 rdf:rest rdf:nil
127 N3c9dd842f0f74ee2983a6af4bc04bf6e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Cell Line, Tumor
129 rdf:type schema:DefinedTerm
130 N4801e2f224ab4a26a468af885e5aca87 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Annexin A2
132 rdf:type schema:DefinedTerm
133 N56685bb6f9ef4482b34995b196ca86c2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Humans
135 rdf:type schema:DefinedTerm
136 N5bc6c15b235f4a5694c9bace227213eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Immunoprecipitation
138 rdf:type schema:DefinedTerm
139 N75f968fa9d954d0e9e1277c635a8b8bd rdf:first sg:person.0741057222.54
140 rdf:rest N1badff11677b476eb116b4e4f827764b
141 N799de97dc9b847608360f85cc747675d schema:name Springer Nature - SN SciGraph project
142 rdf:type schema:Organization
143 N7a04069b61e94e3e98cd328a6ced8e38 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name S100 Proteins
145 rdf:type schema:DefinedTerm
146 N7acf0e312252418c82a6ca11366b99fe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Cell Proliferation
148 rdf:type schema:DefinedTerm
149 N8043ba9bb15048a785d116222b733097 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Cell Movement
151 rdf:type schema:DefinedTerm
152 N8d20b305cc9e42bcabc9b0c206dfdc4e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Cell Cycle Proteins
154 rdf:type schema:DefinedTerm
155 N8d8cb612c37d40669418a67bd45cb7e2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Pancreatic Neoplasms
157 rdf:type schema:DefinedTerm
158 Na1bcc0e5872c4809baeaa9925982c932 rdf:first sg:person.01264420373.12
159 rdf:rest N04bc6049d0404909a8628ca2db6b29ec
160 Na2ae18d3903e48c5a39d2369cc33340c schema:name dimensions_id
161 schema:value pub.1030007607
162 rdf:type schema:PropertyValue
163 Na760a7ff9b3a4162b7047ce9a4076cef rdf:first sg:person.0756336504.39
164 rdf:rest Nc908fe65f6c34db594bec2d300f44c44
165 Na88c7505fa9f46e0adf54efe71eb3e76 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name S100 Calcium Binding Protein A6
167 rdf:type schema:DefinedTerm
168 Naef1a03d7dbe4094a8668190f0167f2d schema:issueNumber 7
169 rdf:type schema:PublicationIssue
170 Nb1501f856a314f6c8560112e0b0b5dde rdf:first sg:person.01234751707.34
171 rdf:rest N75f968fa9d954d0e9e1277c635a8b8bd
172 Nc0af53352ad04b13a968ad3e56baa4e8 rdf:first sg:person.01033302001.43
173 rdf:rest Na1bcc0e5872c4809baeaa9925982c932
174 Nc908fe65f6c34db594bec2d300f44c44 rdf:first sg:person.010730736267.50
175 rdf:rest Nf765ac933e14484c8ecf808eeef5c925
176 Nebd2ba7c404046e5a8ccdfba19c7100c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Cytoplasm
178 rdf:type schema:DefinedTerm
179 Nf765ac933e14484c8ecf808eeef5c925 rdf:first sg:person.0632005147.63
180 rdf:rest Nb1501f856a314f6c8560112e0b0b5dde
181 Nf9c739be3abc4786aa2b1f994f87048b schema:name pubmed_id
182 schema:value 19724273
183 rdf:type schema:PropertyValue
184 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
185 schema:name Medical and Health Sciences
186 rdf:type schema:DefinedTerm
187 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
188 schema:name Oncology and Carcinogenesis
189 rdf:type schema:DefinedTerm
190 sg:grant.2780638 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.bjc.6605289
191 rdf:type schema:MonetaryGrant
192 sg:journal.1017082 schema:issn 0007-0920
193 1532-1827
194 schema:name British Journal of Cancer
195 schema:publisher Springer Nature
196 rdf:type schema:Periodical
197 sg:person.01033302001.43 schema:affiliation grid-institutes:grid.10025.36
198 schema:familyName Nedjadi
199 schema:givenName T
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01033302001.43
201 rdf:type schema:Person
202 sg:person.010730736267.50 schema:affiliation grid-institutes:grid.10025.36
203 schema:familyName Park
204 schema:givenName B K
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010730736267.50
206 rdf:type schema:Person
207 sg:person.01234751707.34 schema:affiliation grid-institutes:grid.39382.33
208 schema:familyName Ashcroft
209 schema:givenName F
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01234751707.34
211 rdf:type schema:Person
212 sg:person.012537142122.12 schema:affiliation grid-institutes:grid.10025.36
213 schema:familyName Neoptolemos
214 schema:givenName J P
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012537142122.12
216 rdf:type schema:Person
217 sg:person.01264420373.12 schema:affiliation grid-institutes:grid.10025.36
218 schema:familyName Kitteringham
219 schema:givenName N
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01264420373.12
221 rdf:type schema:Person
222 sg:person.0632005147.63 schema:affiliation grid-institutes:grid.416319.8
223 schema:familyName Navarro
224 schema:givenName P
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632005147.63
226 rdf:type schema:Person
227 sg:person.0646035141.16 schema:affiliation grid-institutes:grid.10025.36
228 schema:familyName Campbell
229 schema:givenName F
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0646035141.16
231 rdf:type schema:Person
232 sg:person.0667260706.15 schema:affiliation grid-institutes:grid.10025.36
233 schema:familyName Costello
234 schema:givenName E
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0667260706.15
236 rdf:type schema:Person
237 sg:person.0741057222.54 schema:affiliation grid-institutes:grid.10025.36
238 schema:familyName Tepikin
239 schema:givenName A
240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0741057222.54
241 rdf:type schema:Person
242 sg:person.0756336504.39 schema:affiliation grid-institutes:grid.10025.36
243 schema:familyName Jenkins
244 schema:givenName R E
245 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0756336504.39
246 rdf:type schema:Person
247 sg:pub.10.1007/978-1-4020-6191-2_5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052814055
248 https://doi.org/10.1007/978-1-4020-6191-2_5
249 rdf:type schema:CreativeWork
250 sg:pub.10.1038/nrm1661 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033554200
251 https://doi.org/10.1038/nrm1661
252 rdf:type schema:CreativeWork
253 sg:pub.10.1038/sj.onc.1201564 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024213798
254 https://doi.org/10.1038/sj.onc.1201564
255 rdf:type schema:CreativeWork
256 sg:pub.10.1054/bjoc.2000.1356 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050416973
257 https://doi.org/10.1054/bjoc.2000.1356
258 rdf:type schema:CreativeWork
259 grid-institutes:grid.10025.36 schema:alternateName Department of Pathology, University of Liverpool, Liverpool, UK
260 Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK
261 Department of Physiology, University of Liverpool, Liverpool, UK
262 Division of Surgery and Oncology, University of Liverpool, Liverpool, UK
263 schema:name Department of Pathology, University of Liverpool, Liverpool, UK
264 Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK
265 Department of Physiology, University of Liverpool, Liverpool, UK
266 Division of Surgery and Oncology, University of Liverpool, Liverpool, UK
267 rdf:type schema:Organization
268 grid-institutes:grid.39382.33 schema:alternateName Baylor College of Medicine, Houston, TX, USA
269 schema:name Baylor College of Medicine, Houston, TX, USA
270 rdf:type schema:Organization
271 grid-institutes:grid.416319.8 schema:alternateName Cancer Research Programme, Municipal Institute of Medical Research, Barcelona, Spain
272 schema:name Cancer Research Programme, Municipal Institute of Medical Research, Barcelona, Spain
273 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...